HopeStage
Back to all studies
Active Not RecruitingNCT02407808

Cannabinoids, Learning, and Memory

Medication studyAges 18–55United StatesSchizophrenia
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 55 years.

Listed locations
West HavenSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateFebruary 2015
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
80
Sponsor
Yale University
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 55 Years
Official registry ID
NCT02407808
Official title
Show the full official title

Cannabinoids, Learning, and Memory

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Not recruiting

West Haven

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Does this study involve medication?

Yes. The study involves medication, including THC and Placebo.

Who can participate?

Listed age limits: 18 years to 55 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Explore other studies

Want to find a study that may fit you better?

Explore HopeStage studies by mental health topic and refine the results to suit your situation.

Find a study that may fit me